Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans
K. Phan, Mike Angstadt, J. Golden, Ikechukwu C. Onyewuenyi, A. Popovska, H. de Wit
Journal of Neuroscience March 5, 2008 DOI: 10.1523/jneurosci.5603-07.2008 via Semantic Scholar
Summary
AI-generated from the abstractTHC reduces the brain's amygdala response to threatening social signals without affecting primary visual or motor cortex activity. This finding supports the idea that cannabinoids may have an anxiety-reducing role in fear behaviors and suggests potential for new anxiety disorder treatments targeting the cannabinoid system.
Study at a glance
| Characteristics | Randomized controlled trial Double-blind Peer reviewed |
|---|---|
| Sample size | 16 |
| Population | Healthy, recreational cannabis users |
| Intervention | THC |
| Keywords | Medicine Psychology |
| Key finding | THC significantly reduced amygdala reactivity to social signals of threat but did not affect activity in primary visual and motor cortex. |
Abstract
The cannabinoid (CB) system is a key neurochemical mediator of anxiety and fear learning in both animals and humans. The anxiolytic effects of Δ9-tetrahydrocannabinol (THC), the primary psychoactive ingredient in cannabis, are believed to be mediated through direct and selective agonism of CB1 receptors localized within the basolateral amygdala, a critical brain region for threat perception. However, little is known about the effects of THC on amygdala reactivity in humans. We used functional magnetic resonance imaging and a well validated task to probe amygdala responses to threat signals in 16 healthy, recreational cannabis users after a double-blind crossover administration of THC or placebo. We found that THC significantly reduced amygdala reactivity to social signals of threat but did not affect activity in primary visual and motor cortex. The current findings fit well with the notion that THC and other cannabinoids may have an anxiolytic role in central mechanisms of fear behaviors and provide a rationale for exploring novel therapeutic strategies that target the cannabinoid system for disorders of anxiety and social fear.